Knock-Out Finder
Your selection:
28 Results
| MG15FU |  | Neurocrine Biosciences Inc./Faktor/Long [2]/MS | - | - | call | Neurocrine Biosciences Inc. | 87.095 | 92.330 | 2.009 | 47.718% | - | Morgan Stanley | |
| MJ0E7T | | Neurocrine Biosciences Inc./Faktor/Long [3]/MS | - | - | call | Neurocrine Biosciences Inc. | 116.126 | 123.100 | 3.058 | 30.294% | - | Morgan Stanley | |
| MJ6KEQ | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 82.899 | 91.960 | 1.888 | 47.928% | - | Morgan Stanley | |
| MK4AZW | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 67.022 | 67.022 | 1.606 | 62.049% | - | Morgan Stanley | |
| MK4C1R | | Neurocrine Biosciences Inc./Faktor/Long [3]/MS | - | - | call | Neurocrine Biosciences Inc. | 116.126 | 123.100 | 3.066 | 30.294% | - | Morgan Stanley | |
| MK5EAV | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 89.056 | 89.056 | 2.017 | 49.572% | - | Morgan Stanley | |
| MK6B42 | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 110.937 | 110.937 | 2.753 | 37.182% | - | Morgan Stanley | |
| MK6WQ6 | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 99.773 | 110.680 | 2.316 | 37.327% | - | Morgan Stanley | |
| MM1ZCE | | Neurocrine Biosciences Inc./Faktor/Long [4]/MS | - | - | call | Neurocrine Biosciences Inc. | 130.642 | 138.490 | - | 21.580% | - | Morgan Stanley | |
| MM1ZCF | | Neurocrine Biosciences Inc./Faktor/Long [5]/MS | - | - | call | Neurocrine Biosciences Inc. | 139.351 | 147.720 | - | 16.353% | - | Morgan Stanley | |
| MM1ZCG | | Neurocrine Biosciences Inc./Faktor/Long [8]/MS | - | - | call | Neurocrine Biosciences Inc. | 152.416 | 161.570 | - | 8.511% | - | Morgan Stanley | |
| MM1ZCH | | Neurocrine Biosciences Inc./Faktor/Long [10]/MS | - | - | call | Neurocrine Biosciences Inc. | 156.770 | 166.180 | - | 5.900% | - | Morgan Stanley | |
| MM20H2 | | Neurocrine Biosciences Inc./Faktor/Short [5]/MS | - | - | put | Neurocrine Biosciences Inc. | 208.975 | 196.430 | - | 11.229% | - | Morgan Stanley | |
| MM3TGR | | Neurocrine Biosciences Inc./KO/Put [endlos]/MS | - | - | put | Neurocrine Biosciences Inc. | 198.737 | 198.737 | - | 12.535% | - | Morgan Stanley | |
| MN11NQ | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 75.249 | 83.470 | 1.745 | 52.735% | - | Morgan Stanley | |
| MN4HCE | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 111.627 | 123.830 | 2.733 | 29.881% | - | Morgan Stanley | |
| MN8PJF | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 122.346 | 122.346 | - | 30.721% | - | Morgan Stanley | |
| MN8PXN | | Neurocrine Biosciences Inc./Faktor/Long [8]/MS | - | - | call | Neurocrine Biosciences Inc. | 152.416 | 161.570 | - | 8.511% | - | Morgan Stanley | |
| MN8PXP | | Neurocrine Biosciences Inc./Faktor/Long [10]/MS | - | - | call | Neurocrine Biosciences Inc. | 156.770 | 166.180 | - | 5.900% | - | Morgan Stanley | |
| MN8Q42 | | Neurocrine Biosciences Inc./Faktor/Short [4]/MS | - | - | put | Neurocrine Biosciences Inc. | 217.682 | 204.620 | - | 15.866% | - | Morgan Stanley | |
| MN8Q43 | | Neurocrine Biosciences Inc./Faktor/Short [8]/MS | - | - | put | Neurocrine Biosciences Inc. | 195.914 | 184.150 | - | 4.275% | - | Morgan Stanley | |
| MN8Q44 | | Neurocrine Biosciences Inc./Faktor/Short [10]/MS | - | - | put | Neurocrine Biosciences Inc. | 191.560 | 180.060 | - | 1.959% | - | Morgan Stanley | |
| MN96CX | | Neurocrine Biosciences Inc./Faktor/Long [1,5]/MS | - | - | call | Neurocrine Biosciences Inc. | 58.063 | 61.550 | - | 65.147% | - | Morgan Stanley | |
| MN9L0F | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 128.187 | 142.200 | 3.699 | 19.479% | - | Morgan Stanley | |
| MR2RTZ | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 140.727 | 140.727 | - | 20.313% | - | Morgan Stanley | |
| MR3G22 | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 144.663 | 160.470 | - | 9.134% | - | Morgan Stanley | |
| MR3HS1 | | Neurocrine Biosciences Inc./Faktor/Short [2]/MS | - | - | put | Neurocrine Biosciences Inc. | 261.219 | 245.540 | - | 39.037% | - | Morgan Stanley | |
| MR3HS2 | | Neurocrine Biosciences Inc./Faktor/Short [3]/MS | - | - | put | Neurocrine Biosciences Inc. | 232.194 | 218.260 | - | 23.590% | - | Morgan Stanley |